Celldex's Participation in Key Investor Conferences
Management from Celldex (NASDAQ:CLDX) recently announced their upcoming participation in several investor conferences aimed at providing insights into the company's innovative work in immunology. These events are pivotal platforms for investors and stakeholders to engage with industry leaders and gain insights into the latest advancements in biotechnology.
Upcoming Conference Dates
Celldex will be actively participating in a series of important conferences, including:
- The Guggenheim 2nd Annual Healthcare Innovation Conference, scheduled for Tuesday at 10:00 am ET.
- The TD Cowen Immunology & Inflammation Summit, set for Thursday at 9:30 am ET.
- The 8th Annual Evercore Healthcare Conference on December 2 at 3:00 pm ET.
These engagements represent an excellent opportunity for Celldex to connect with investors, share their vision, and discuss the innovative pathways they are pursuing to improve patient care through their developments in immune response therapies.
Importance of Webcast Presentations
The presentations from these conferences will be available via live webcasts, allowing a broader audience to access critical information and insights beyond those who can attend in person. Participants can find these live streams on the "Events & Presentations" section of Celldex's investor website. Moreover, replays will be accessible for 90 days post-event to ensure that stakeholders do not miss any vital updates.
About Celldex's Mission
At the core of Celldex's efforts is a commitment to revolutionizing healthcare through innovative immunology solutions. The company is engaged in developing antibody-based treatments designed to interact with the human immune system, focusing on addressing various allergic, inflammatory, and autoimmune conditions.
This relentless pursuit of medical advancement showcases their dedication to providing life-changing therapies for patients. The company's commitment to research and development is evident as they continue to explore new treatment options and pathways.
Connecting with Celldex
If you are interested in learning more about Celldex and its innovative approaches to immunological therapies, the following contacts are available:
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
Frequently Asked Questions
What is the main focus of Celldex?
Celldex focuses on pioneering immunology therapies that can significantly improve the lives of patients suffering from various disorders.
When will the conferences take place?
The conferences will occur on November 11, November 13, and December 2, providing a timeline of engagement for investors.
How can I access the live presentations?
Live webcasts of the presentations will be available on the "Events & Presentations" page on Celldex's investor website.
Is there a way to watch the presentations after they occur?
Yes, Celldex will provide replays of the presentations for 90 days following the events.
Who can I contact for more information about Celldex?
For further inquiries, you can reach out to Sarah Cavanaugh or Patrick Till using their provided email addresses or phone numbers.